Glutathione synthesis and antioxidant defense pathways

The glutathione synthesis and antioxidant defense pathways represent a critical cellular network responsible for maintaining redox homeostasis and protecting cells from oxidative damage (Source: NIH, PMC4684116). Glutathione (GSH), a tripeptide composed of glutamate, cysteine, and glycine, serves as the primary endogenous antioxidant. Its synthesis is a two-step process catalyzed by glutamate-cysteine ligase (GCL) and glutathione synthetase (GSS) (Source: UniProt). The antioxidant defense component utilizes GSH as a cofactor for enzymes such as glutathione peroxidase (GPx) to neutralize reactive oxygen species (ROS) and glutathione S-transferases (GST) for the detoxification of xenobiotics (Source: StatPearls). Dysregulation of these pathways is implicated in numerous pathologies, including cancer, where elevated GSH can confer drug resistance, and neurodegenerative diseases like Parkinson's, where GSH depletion leads to neuronal death (Source: PubMed, 28915117). Pharmacological intervention strategies include the use of GSH precursors like N-acetylcysteine to bolster defenses or inhibitors like buthionine sulfoximine to sensitize cancer cells to chemotherapy (Source: PubChem).

Other names

Glutathione metabolismGSH systemRedox homeostasis pathwayGlutathione-dependent antioxidant system

Drugs targeting this pathway typically act by providing rate-limiting precursors (e.g., cysteine), inhibiting key synthetic enzymes like glutamate-cysteine ligase, or inducing the expression of antioxidant enzymes through the Nrf2/ARE signaling axis (Source: PubMed, 22649244).